Cardiovascular Disease
Showing NaN - NaN of 32
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014
Type 2 Diabetes, Cardiovascular Disease, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- Dapagliflozin
- Placebo
-
Birmingham, Alabama
- +134 more
Dec 18, 2013
Type 2 Diabetes, Cardiovascular Disease, Hypertension Trial in Worldwide (Dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +3 more
- Dapagliflozin
- Placebo
-
Gulf Shores, Alabama
- +140 more
Sep 24, 2013
What is the Optimal Method for Ischemia Evaluation in WomeN?
Completed
- Coronary Artery Disease
- +4 more
-
Tucson, Arizona
- +42 more
Jul 31, 2012
Cardiovascular Disease, de Novo Coronary Lesions Trial in United States (TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent
Completed
- Cardiovascular Disease
- de Novo Coronary Lesions
- TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System
-
Scottsdale, Arizona
- +52 more
Sep 25, 2008
StarClose™ Vascular Closure System
Completed
- Peripheral Vascular Disease
- Cardiovascular Disease
- Vessel Closure (StarClose™)
-
La Jolla, California
- +10 more
Aug 14, 2008